Johnson & Johnson Initiates 5-Year Safety Study for Mentor Breast Implants in China
Johnson & Johnson is conducting a 5-year observational study to evaluate the long-term safety of Mentor breast implants in the Chinese population.
Asset / Drug
Drug and asset intelligence for Johnson with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.